These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 25375070)

  • 21. Pneumonia hospitalizations among young children before and after introduction of pneumococcal conjugate vaccine--United States, 1997-2006.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2009 Jan; 58(1):1-4. PubMed ID: 19145219
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pneumonia hospitalization after introduction of pneumococcal conjugate vaccine in Japan: Descriptive study using a nationwide claims database.
    Yanai T; Yoshida S; Takeuchi M; Kawakami K
    Vaccine; 2023 Jun; 41(29):4313-4318. PubMed ID: 37286407
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of introduction of conjugate vaccines in the vaccination schedule on the incidence of pediatric invasive pneumococcal disease requiring hospitalization in Madrid 2007 to 2011.
    Picazo J; Ruiz-Contreras J; Casado-Flores J; Giangaspro E; García-de-Miguel MJ; Hernández-Sampelayo T; Otheo E; Méndez C;
    Pediatr Infect Dis J; 2013 Jun; 32(6):656-61. PubMed ID: 23249906
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of the 13-valent pneumococcal conjugate vaccine on the incidences of community-acquired pneumonia and pneumonia-related hospitalizations in children ≤5 years after its implementation into the national immunization program of Turkey.
    Gönüllü E; Soysal A; Yıldız I; Aydemir G; Tunç T; Karaböcüoğlu M
    Hum Vaccin Immunother; 2020 Oct; 16(10):2504-2508. PubMed ID: 32119602
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recommendations for the prevention of Streptococcus pneumoniae infections in infants and children: use of 13-valent pneumococcal conjugate vaccine (PCV13) and pneumococcal polysaccharide vaccine (PPSV23).
    American Academy of Pediatrics Committee on Infectious Diseases
    Pediatrics; 2010 Jul; 126(1):186-90. PubMed ID: 20498180
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cost-effectiveness of a 10- versus 13-valent pneumococcal conjugate vaccine in Denmark and Sweden.
    Klok RM; Lindkvist RM; Ekelund M; Farkouh RA; Strutton DR
    Clin Ther; 2013 Feb; 35(2):119-34. PubMed ID: 23312274
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antibiotic resistance and serotype distribution of invasive pneumococcal diseases before and after introduction of pneumococcal conjugate vaccine in the Kingdom of Saudi Arabia (KSA).
    Shibl AM; Memish ZA; Al-Kattan KM
    Vaccine; 2012 Dec; 30 Suppl 6():G32-6. PubMed ID: 23228355
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Invasive pneumococcal disease and 13-valent pneumococcal conjugate vaccine (PCV13) coverage among children aged ≤59 months---selected U.S. regions, 2010--2011.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2011 Nov; 60(43):1477-81. PubMed ID: 22048728
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of 13-Valent Pneumococcal Conjugate Vaccine on Meningitis and Pneumonia Hospitalizations in Children aged <5 Years in Senegal, 2010-2016.
    Faye PM; Sonko MA; Diop A; Thiongane A; Ba ID; Spiller M; Ndiaye O; Dieye B; Mwenda JM; Sow AI; Diop B; Diallo A; Farrar JL
    Clin Infect Dis; 2019 Sep; 69(Suppl 2):S66-S71. PubMed ID: 31505625
    [TBL] [Abstract][Full Text] [Related]  

  • 30. U.S. hospitalizations for pneumonia after a decade of pneumococcal vaccination.
    Griffin MR; Zhu Y; Moore MR; Whitney CG; Grijalva CG
    N Engl J Med; 2013 Jul; 369(2):155-63. PubMed ID: 23841730
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pneumococcal conjugate vaccine-elicited antibody persistence and immunogenicity and safety of 13-valent pneumococcal conjugate vaccine in children previously vaccinated with 4 doses of either 7-valent or 13-valent pneumococcal conjugate vaccine.
    Quinet B; Laudat F; Gurtman A; Patterson S; Sidhu M; Gruber WC; Scott DA
    Pediatr Infect Dis J; 2014 Oct; 33(10):1065-76. PubMed ID: 25093973
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The impact of pneumococcal conjugate vaccine on community-acquired pneumonia hospitalizations in children with comorbidity.
    Sterky E; Bennet R; Lindstrand A; Eriksson M; Nilsson A
    Eur J Pediatr; 2017 Mar; 176(3):337-342. PubMed ID: 28070670
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Invasive pneumococcal disease in children 5 years after conjugate vaccine introduction--eight states, 1998-2005.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2008 Feb; 57(6):144-8. PubMed ID: 18272956
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Invasive pneumococcal disease in young children before licensure of 13-valent pneumococcal conjugate vaccine - United States, 2007.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2010 Mar; 59(9):253-7. PubMed ID: 20224541
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The impact of pneumococcal conjugate vaccine on the prevalence and severity of hospitalizations for pneumonia in children.
    Eichler N; Joseph L; Megged O; Goldberg S; Picard E
    Eur J Clin Microbiol Infect Dis; 2022 Mar; 41(3):439-444. PubMed ID: 34997390
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acquisition of Streptococcus pneumoniae in South African children vaccinated with 7-valent pneumococcal conjugate vaccine at 6, 14 and 40 weeks of age.
    Nunes MC; Jones SA; Groome MJ; Kuwanda L; Van Niekerk N; von Gottberg A; de Gouveia L; Adrian PV; Madhi SA
    Vaccine; 2015 Jan; 33(5):628-34. PubMed ID: 25541213
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term immune responses to pneumococcal conjugate vaccines in children previously vaccinated with 7-valent pneumococcal conjugate vaccine.
    Klein NP; Ensor K; Jouve S; Northington R; Moscariello M; McGovern PC
    Pediatr Infect Dis J; 2013 Sep; 32(9):990-7. PubMed ID: 24008739
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased paediatric hospitalizations for empyema in Australia after introduction of the 7-valent pneumococcal conjugate vaccine.
    Strachan RE; Snelling TL; Jaffé A
    Bull World Health Organ; 2013 Mar; 91(3):167-73. PubMed ID: 23476089
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Changes in Childhood Pneumonia Hospitalizations by Race and Sex Associated with Pneumococcal Conjugate Vaccines.
    Wiese AD; Grijalva CG; Zhu Y; Mitchel EF; Griffin MR
    Emerg Infect Dis; 2016 Jun; 22(6):1109-12. PubMed ID: 27197048
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Changes in childhood pneumonia and infant mortality rates following introduction of the 13-valent pneumococcal conjugate vaccine in Nicaragua.
    Becker-Dreps S; Amaya E; Liu L; Moreno G; Rocha J; Briceño R; Alemán J; Hudgens MG; Woods CW; Weber DJ
    Pediatr Infect Dis J; 2014 Jun; 33(6):637-42. PubMed ID: 24445827
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.